Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Kawakami
Impact of CYP2D6 Phenotype on Tramadol Pharmacokinetics and Metabolic Pathways in Cancer Patients
Clinical Therapeutics
Pharmacology
Characterization of Bis-8-Hydroxyquinoline-Armed Diazatrithia-16-Crown-5 and Diazadibenzo-18-Crown-6 Ligands as Fluorescent Chemosensors for Zinc
Related publications
Impact of CYP2D6*10 on Venlafaxine and Its Desmethylated Metabolite Pharmacokinetics in Japanese Psychiatric Patients
Proceedings for Annual Meeting of The Japanese Pharmacological Society
Impact of CYP2D6*10 Polymorphism on the Pharmacokinetics of Mirtazapine and Its Desmethylated Metabolite in Japanese Psychiatric Patients Treated With Mirtazapine
Clinical Neuropsychopharmacology and Therapeutics
Psychiatry
Mental Health
Neurology
Pharmacology
Inhibition of CYP2D6-mediated Tramadol O-Demethylation in Methadone but Not Buprenorphine Maintenance Patients
British Journal of Clinical Pharmacology
Pharmacology
Effects ofFlos Carthamion CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats
Evidence-based Complementary and Alternative Medicine
Alternative Medicine
Complementary
Significantly Lower CYP2D6 Metabolism Measured as the O/N -Desmethylvenlafaxine Metabolic Ratio in Carriers of CYP2D6*41 Versus CYP2D6*9 or CYP2D6*10 - A Study on Therapeutic Drug Monitoring Data From 1,003 Genotyped Scandinavian Patients
British Journal of Clinical Pharmacology
Pharmacology
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
Pharmaceuticals
Molecular Medicine
Pharmaceutical Science
Effect of Cyp2d6 Genetic Polymorphism on the Pharmacokinetics of Multiple-Dose Metoclopramide
Clinical Therapeutics
Pharmacology
Breast Cancer Screening: Impact on Care Pathways
Cancer Medicine
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Clinical Pharmacokinetics of Aztreonam in Cancer Patients.
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
